Titled, "Gliadin intake alters the small intestinal mucosa in indomethacin-treated HLA-DQ8 transgenic mice," the animal study concluded that the protein gliadin (one of several prolamine proteins in wheat together colloquially known as a 'gluten'), '...in combination with COX inhibition [produced through indomethacin treatment] caused a basal inflammatory status and an oxidative stress condition in the small intestine of DQ8 mice [a celiac disease susceptibility gene], thus triggering the mucosal lesion and, subsequently, an antigen-specific immunity."
Source : >